New drugs, new challenges for dermatologists: mucocutaneous ulcers secondary to everolimus

• Үндсэн зохиолчид: Victor Pavan Pasin (Зохиогч), Amanda Regio Pereira (Зохиогч), Kalline Andrade de Carvalho (Зохиогч), João Marcos Góes de Paiva (Зохиогч), Milvia Maria Simões e Silva Enokihara (Зохиогч), Adriana Maria Porro (Зохиогч)
• Формат: Ном
• Хэвлэсэн: Sociedade Brasileira de Dermatologia, 2015-06-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

AbstractEverolimus, a mammalian target of rapamycin inhibitor, is an emerging drug, which is being increasingly applied in oncology and solid organ transplantation. Oral ulcers are a frequent side effect associated with this immunosupressor. We report the case of a renal transplant recipient who dev...